GlassScriptPhysician profile
Sudeshna Banerjee
NPI 1093926081
$66,336.52
in general payments reported to CMS, 2019-2025
16 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,663 · 2020: $5,831 · 2021: $10K · 2022: $12K · 2023: $2,828 · 2024: $15K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $8,084 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,600 · Travel and Lodging: $5,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,187.50 |
| Food and Beverage | $8,084.32 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,600.00 |
| Travel and Lodging | $5,234.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18,769.32 | 2019-2025 | Sentinel, Avvigo Guidance System, Synergy |
| Abbott Laboratories | $17,673.52 | 2019-2025 | Triclip, Mitraclip, Ultreon |
| Medtronic, INC. | $9,639.00 | 2022-2025 | Corevalve Evolut R |
| Shockwave Medical, INC | $9,054.45 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $2,939.22 | 2019-2022 | |
| Edwards Lifesciences Corporation | $2,888.80 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $2,638.98 | 2019 | |
| Philips North America LLC | $1,023.67 | 2019-2024 | (Bq9) Coronary Ivus |
| Inari Medical, INC. | $556.46 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $438.59 | 2020-2024 | Impella |
| Biotronik INC. | $342.79 | 2019-2024 | Amvia Edge, Acticor 7 Vr-T Dx |
| Siemens Medical Solutions USA, INC. | $138.80 | 2019-2021 | |
| Cardiovascular Systems INC. | $124.97 | 2019 | |
| Cardiva Medical, INC. | $49.65 | 2021 | |
| Corindus INC. | $39.21 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $19.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sudeshna Banerjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.